Cognetivity Neurosciences Ltd.
OTC: CGNSF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Sina Habibi
- Employees
- 2,500
- Headquarters
- Vancouver, Canada
- IPO year
- 2021
- Market cap
- $9.0K
- Website
- https://www.cognetivity.com
Loading CGNSF…
Loading profile data…Frequently asked questions about CGNSF
What does Cognetivity Neurosciences Ltd. (CGNSF) do?
Cognetivity Neurosciences Ltd. is a healthcare firm focused on advanced cognitive assessment. The company has developed a sophisticated platform for cognitive testing, designed for use across diverse settings including medical facilities, commercial environments, and by individual consumers. This innovative system's primary goal is to identify t...
Where does CGNSF trade?
Cognetivity Neurosciences Ltd. (CGNSF) trades on the Other OTC.
What sector is CGNSF in?
Cognetivity Neurosciences Ltd. (CGNSF) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of Cognetivity Neurosciences Ltd.?
Sina Habibi is the chief executive officer of Cognetivity Neurosciences Ltd. (CGNSF).
Where is Cognetivity Neurosciences Ltd. headquartered?
Cognetivity Neurosciences Ltd. is headquartered in Canada.
Does CGNSF pay a dividend?
Cognetivity Neurosciences Ltd. (CGNSF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CGNSF go public?
Cognetivity Neurosciences Ltd. (CGNSF) completed its initial public offering in 2021.